Desk› Healthcare› Anthem Biosciences Ltd

Anthem Biosciences Ltd

BSE 544449 ANTHEM INE0CZ201020

Healthcare Healthcare Pharmaceuticals & Biotechnology Biotechnology NIFTY 500

Filing rhythm · 60 trading days

25 filings · 8 material · busiest 2026-07-21

What it files

AGM / EGM3 Analyst / Investor Meet3 Newspaper Publication2 Investor Presentation2 Press Release2 General2 Annual Report2 Concall Transcript1

Filings

25 in the window

27 July 2026

Concall Transcript

Earnings Call Transcript

Transcript of Earnings Conference Call held on July 22, 2026.

Company Update / Earnings Call Transcript View filing →
24 July 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Anthem Biosciences Limited has submitted the Exchange the voting results and a copy of scrutinizer report of the 20th Annual General Meeting of the Company held on July 22, 2026

AGM/EGM / AGM View filing →
22 July 2026

Newspaper Publication

Newspaper Publication

Newspaper Publication on Unaudited Consolidated and Standalone Financial Results for the quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →
22 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Audio recording of Earnings Call for the quarter ended June 30, 2026.

Company Update / Analyst / Investor Meet View filing →
22 July 2026

AGM / EGM

Announcement Under

Anthem Biosciences Limited has informed the Exchange regarding the Proceedings of the 20th Annual General Meeting held on Wednesday, July 22, 2026

AGM/EGM / AGM View filing →
21 July 2026

Board Outcome

Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, July 21, 2026

Outcome of the Board Meeting held on Tuesday, July 21, 2026

Board Meeting / Outcome of Board Meeting View filing →
21 July 2026

Results

Financial Results For The Quarter Ended June 30, 2026

Financials Results for the quarter ended June 30, 2026

Result / Financial Results View filing →
21 July 2026

Investor Presentation

Investor Presentation

Investor Presentation on Unaudited Consolidated Financial Results for the quarter ended June 30, 2026`

Company Update / Investor Presentation View filing →
21 July 2026

Press Release

Press Release / Media Release

Press Release on Consolidated Financial Results for the quarter ended June 30, 2026

Company Update / Press Release / Media Release View filing →
21 July 2026

Investor Presentation

Investor Presentation

Revised Investor Presentation for Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2026

Company Update / Investor Presentation View filing →
21 July 2026

Press Release

Press Release / Media Release (Revised)

Revised Press Release on Unaudited Financial Results for the quarter ended June 30, 2026

Company Update / Press Release / Media Release (Revised) View filing →
15 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Intimation of Schedule of Earnings Conference Call to discuss on Unaudited Standalone and Consolidated Financial Results for quarter ended June 30, 2026

Company Update / Analyst / Investor Meet View filing →
14 July 2026

Board Meeting

Board Meeting Intimation for Financial Results For Quarter Ended June 30, 2026

Anthem Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2026 ,inter alia, to consider and approve Unaudited Standalone and ....

Board Meeting / Board Meeting View filing →
10 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation under 74(5) of SEBI (DP) Regulations, 2018

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
8 July 2026

General

Letter To Shareholders

Letter to Shareholders providing the weblink and navigation path for accessing the Annual Report for the FY 2025-26 pursuant to Regulation 36(1)(b) of LODR.

Company Update / General View filing →
3 July 2026

Credit Rating

Credit Rating

Intimation of Revision in Credit Rating

Company Update / Credit Rating View filing →
1 July 2026

General

Newspaper Publication

Newspaper advertisement regarding the completion of dispatch of notice of the 20th Annual General Meeting of the Company

Company Update / General View filing →
30 June 2026

AGM / EGM

Notice Of The 20Th Annual General Meeting ('AGM')

Notice of the 20th Annual General Meeting

AGM/EGM / AGM View filing →
30 June 2026

Annual Report

Reg. 34 (1) Annual Report.

Annual Report for the FY 2025-26

Others / Reg. 34 (1) Annual Report View filing →
30 June 2026

BRSR

Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report (BRSR) for the FY 2025-2026

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
30 June 2026

Annual Report

Reg. 34 (1) Annual Report.

Revised Annual Report for the FY 2025-26

Others / Reg. 34 (1) Annual Report View filing →
29 June 2026

Newspaper Publication

Newspaper Publication

Newspaper Advertisement regarding pre-dispatch intimation of Notice of 20th Annual General Meeting of the Company

Company Update / Newspaper Publication View filing →
26 June 2026

Trading Window

Closure of Trading Window

Closure of Trading Window for the quarter ended June 30, 2026

Insider Trading / SAST / Closure of Trading Window View filing →
19 June 2026

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aruna Ganesh

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
5 June 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Schedule of Institutional Call to be held on June 10, 2026

Company Update / Analyst / Investor Meet View filing →